• Profile
Close

Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer

World Journal of Urology Sep 25, 2020

Kimura S, D’Andrea D, Iwata T, et al. - Among patients who underwent radical prostatectomy (RP) for prostate cancer (PCa), this inquiry was performed to determine the prognostic role of expression of urokinase-type plasminogen activator system members, such as urokinase-type activator (uPA), uPA-receptor (uPAR), and plasminogen activator inhibitor-1 (PAI-1). This analysis included 3,121 patients who were treated with RP. In 1,012 (32.4%), 1,271 (40.7%), and 1,311 (42%) patients, the overexpression of uPA, uPAR, and PAI-1 was identified, respectively. Findings revealed that overexpression of uPA, uPAR, and PAI-1 in PCa tissue were each related to worse biochemical recurrence. Even in cases with favorable pathologic features, overexpression of all three markers was identified to be informative potentially assisting clinical decision-making about adjuvant treatment and/or intensified follow-up.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay